NY-ESTÉE-LAUDER
16.7.2024 07:31:34 CEST | Business Wire | Press release
The Estée Lauder Companies (NYSE: EL) (“ELC”) is pleased to announce the third edition of BEAUTY&YOU India. Created by ELC’s New Incubation Ventures (“NIV”) and launched in partnership with India’s preferred beauty and lifestyle retailer - NYKAA, BEAUTY&YOU India continues its mission to discover, spotlight, and propel the next generation of India-focused beauty brands. The program supports India-focused companies, entrepreneurs, innovators, and creators through a competitive application process that will be open to prospective applicants on July 16, 2024, through August 29, 2024, via www.beautyandyouawards.com. Winners will be announced on November 16, 2024, at a live event in Goa.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240715092980/en/
Introducing BEAUTY&YOU India 2024: Fueling Innovation in the Indian Beauty Landscape (Photo: Business Wire)
The 2024 program builds on the success of previous years with the theme of Supercharged Futures. The beauty opportunity in India continues to grow with more brands, increased innovation, significant investment dollars, and a consumer base looking for the best solutions. BEAUTY&YOU India 2024 seeks applicants with a supercharged vision for the future of Indian beauty and its impact on the broader beauty ecosystem. This encompasses companies with social initiatives that enhance the lives of their communities and the ecosystems in which they operate. It also includes founders who are developing new technologies, ingredients, or solutions that address existing challenges for Indian beauty consumers while driving innovation across Skin Care, Makeup, Hair Care and Fragrance categories.
An exciting addition to this year's program is that winners will have access to the BEAUTY&YOU India Bootcamp, featuring one-on-one mentorship sessions with industry leaders Falguni Nayar, Founder & Chief Executive Officer, NYKAA; Sabyasachi Mukherjee, Founder, Sabyasachi; and Rohan Vaziralli, General Manager, ELCA Cosmetics Private Limited. This unique opportunity is designed to provide the winners with invaluable insights and mentorship from these experts and affirms the program’s commitment to fostering the growth and development of the next generation of Indian-focused beauty entrepreneurs.
From the first edition in 2022 to the second in 2023, the applicant pool doubled in size. This growth has significantly enhanced the visibility and opportunities for the winners, underscoring the program's positive impact.
“India represents one of the most exciting global economies for beauty today. A growing consumer base, an exciting retail landscape, and one of the most powerful entertainment markets in the world continue to fuel unprecedented growth. The market is poised to continue to drive both national and global trends. We are excited to support the founders and creators in their journey,” said Shana Randhava, Senior Vice President, New Incubation Ventures, ELC.
"The global recognition of India’s potential as both a powerful consumer market and entrepreneurial hub is more evident now than ever before. NYKAA is proud to be a part of nurturing this ecosystem,” said Anchit Nayar, Executive Director & CEO, NYKAA Beauty. “In its third edition, BEAUTY&YOU India is more than just a platform — it's a gateway for Indian entrepreneurs to showcase their creativity and rigor on a global stage and we are excited to be part of their future.”
"Participating in BEAUTY&YOU India since its first edition has been an immensely rewarding experience, particularly in seeing its transformative impact on the Indian beauty industry. The program enhances the trajectory of emerging brands by providing a platform that fosters growth, innovation, and visibility,” said 2024 BEAUTY&YOU India judge Katrina Kaif, Actor and Co-Founder, Kay Beauty, “In my role as the co-founder of Kay Beauty, I have a deep appreciation for such platforms that support entrepreneurs in their journey. As we enter the third edition, I am as excited and committed as ever to discover and support brands that are shaping the future of beauty in India."
2024 Prize Program
The following prizes are open to founders, companies, and creatives meeting specific application criteria available at www.beautyandyouawards.com/application-criteria. The following awards will be presented across categories in Skin Care, Make Up, Hair Care, Personal Fragrance, and Home Fragrance:
- IMAGINE: Pre-Launch Beauty Concepts
- GROW: In-Market Beauty Concepts
- CREATE: The Next Generation of Creative Talent (e.g., photographers, filmmakers, etc.) Submitting Work Around the Theme of ‘Supercharged Futures’
Among other resources, BEAUTY&YOU India 2024 will provide award recipients with financial support (a prize pool up to 4 Crore or $500k), distribution channel access, mentorship, and access to research and innovation resources.
The BEAUTY&YOU 2024 website and application portal go live July 16, 2024, and will accept applications until August 29, 2024, 11:59 PM IST. Full program details are available at www.beautyandyouawards.com.
2024 Judges
Shana Randhava
Senior Vice President, New Incubation Ventures, The Estée Lauder Companies
Anchit Nayar
Executive Director & CEO, NYKAA Beauty
Katrina Kaif
Actor and Co-Founder, Kay Beauty
Gaurav Gupta
Couturier, Artist and Designer
Anaita Shroff Adajania
Stylist, Creative Director & Founder, Style Cell
Samrath Bedi
Executive Director, Forest Essentials
Diipa Büller-Khosla
Founder, indē wild
Sandhya Devanathan
Vice President & Head – India, Meta
Rohan Vaziralli
General Manager, ELCA Cosmetics Private Limited
Jaffrey Zaman
Managing Director, Intercos India Private Limited
Gianandrea Ferrari
CEO, Intercos Europe, Middle East & India
Sumit Bhasin
Senior Vice President, Global Fragrance Innovation, Product Development & R&D, The Estée Lauder Companies
Dr. Jaishree Sharad
Celebrated Cosmetic Dermatologist, author and TEDx Speaker
Shruti Chandra,
Vice President, Invest India and Vice Chair, Women Empowerment, Europe India Council for Business and Industry (EICBI)
Rochelle Pinto
Head of Editorial Content, Vogue India
Sujata Assomull
Contributing Editor, Vogue Business
Deepica Mutyala
Founder and CEO, Live Tinted
About BEAUTY&YOU India
BEAUTY&YOU aims to help founders, innovators and creators grow their businesses holistically by identifying brand goals, achieving scale ambitions and curating product portfolios that speak to a new generation of Indian consumers.
About The Estée Lauder Companies’ New Incubation Ventures
New Incubation Ventures (NIV) is the strategic early-stage investment and incubation arm for The Estée Lauder Companies. NIV partners with forward-thinking founders and entrepreneurs to create, fund, and support the best-emerging beauty brands and new business models to shape the future of beauty and build an actionable pipeline of diversified brands and new engines of growth for the ELC portfolio.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.
About NYKAA
Born out of a desire to make beauty a mainstream choice, Nykaa began in 2012 as a digitally native, consumer-tech company. Through founder Falguni Nayar’s vision to bring inspiration and joy to people everywhere, it tapped into an underserved beauty retail market, disrupting the ecosystem and putting India in the global spotlight. Today, Nykaa has expanded its offerings to include lifestyle and B2B by introducing online platforms Nykaa Fashion, Nykaa Man and Superstore.
Over the years, Nykaa has steadily captured the hearts of Indian consumers, ushering visits to its online and 175 offline destinations and building loyal communities through engaging and educational content. Nykaa continues to build its house of brands with a sharp focus on innovation and consumer delight. Beauty brands such as Kay Beauty, Nykaa Naturals, Nykaa Cosmetics and Wanderlust along with fashion brands such as Nykd, Gajra Gang, Likha, RSVP and Pipa Bella have become household names as they consistently deliver inspiration and high-performing products to the consumers.
Nykaa’s unwavering commitment to authenticity and putting the customer at the heart of everything that they do has made it the retailer of choice for international brands entering India. Its Global Store, a gateway into the world of coveted international brands, leverages the company’s proven supply chain and marketing capabilities to offer a truly seamless shopping experience.
Website: www.beautyandyouawards.com
Instagram: @beautyandyouawards
ELC-C
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240715092980/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mosaic Therapeutics to Present Poster Highlighting Preclinical Data for Lead Program MOS101 at the American Association for Cancer Research (AACR) Annual Meeting 202624.3.2026 09:30:00 CET | Press release
First preclinical data on the Company’s lead program MOS101: a combination of ASTX295, a next-generation, clinical-stage MDM2 antagonist, and olaparib, an FDA-approved PARP inhibitor, in biomarker-selected solid tumorsAdditional data showcasing Mosaic’s Discovery Platform, PRIME, will be presented Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company building the category leader in Synergistic Precision Oncology, today announced it will hold a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego, CA. Poster Presentation Details: Title: "Combination of the MDM2 antagonist ASTX295 and olaparib as a novel treatment option for BRCA2 mutant, TP53 wild-type solid tumors” Abstract Number: 3053 Date and Time: Monday, April 20, 2026, 2:00PM – 5:00PM PST Session Category: Novel Targets and Pathways Session: PO.ET09.09 Location: Poster Section 15 For more information an
Vonage and ServiceNow Expand their Partnership24.3.2026 09:20:00 CET | Press release
Vonage Contact Center with ServiceNow Voice integrates enterprise-grade voice and AI capabilities directly into enterprise workflows, boosting agent productivity and customer engagement Vonage, part of Ericsson (NASDAQ: ERIC), today announced the launch of its native integration with ServiceNow Voice, built on the ServiceNow AI Platform, embedding enterprise-grade voice and real-time AI capabilities directly into ServiceNow Customer Service Management (CSM) and IT Service Management (ITSM) workflows for Vonage Contact Center (VCC) customers. Vonage provides a unified service environment for enterprise customer service and IT support teams, enabling agents to deliver exceptional customer experiences while driving improvements to service performance. The integration of VCC with ServiceNow embeds real-time voice and AI capabilities into enterprise workflows, giving them the tools their agents need to streamline case progression, automate workflows, and reduce manual effort. Through the Vo
Omnes Partners With Apex Group to Tokenise Institutional Bitcoin Mining Structured Note on Base24.3.2026 09:00:00 CET | Press release
Omnes today announced a strategic partnership with Apex Group, a leading global financial services provider with over $3.5 trillion in assets serviced, to tokenise its flagship Omnes Mining Note "OMN". The OMN is an institutional grade structured note backed by Bitcoin hashrate, to be issued and managed on the Base Chain, the Ethereum L2 incubating at Coinbase, leveraging Apex Digital 3.0 for comprehensive tokenisation, administration, and transfer agency services as a fully integrated end to end solution. The OMN provides professional non-US investors with direct economic exposure to new Bitcoin production measured in hashrate, which is the computational power used to validate transactions and produce Bitcoin, without the operational complexities of managing mining infrastructure, hardware, energy, or regulatory hurdles. Issued as a secured debt note in Luxembourg, the tokenised OMN combines traditional financial structuring with blockchain enabled features, including on chain transfe
Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved24.3.2026 07:00:00 CET | Press release
Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory submission supporting a pivotal study in patients suffering from peritumoral brain edema (PTBE). In November 2025, Curatis raised CHF 1.2m to progress corticorelin. The cash position as of year end 2025 was comfortable, standing at CHF 1.9m. Recently, Curatis announced a license agreement for corticorelin for Japan with significant milestone payments. Business development and finances In 2025, product sales amounted to CHF 10.3m, while service revenue amounted to CHF 0.5m. On a full year basis, Curatis AG increased revenues in its distri
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 07:00:00 CET | Press release
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio® (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatric patients, and share four posters on AKLIEF® (trifarotene)1-8 Additional presentations related to Dermatological Skincare will explore how artificial intelligence can identify high-risk factors for sensitive skin and Cetaphil® in different skin types9 Data from Galderma’s Injectable Aesthetics portfolio will also show how its hyaluronic acid injectables, Restylane®, and neuromodulator, RelabotulinumtoxinA*, may address aesthetic needs across the face and décolletage10-14 A total of 22 presentations will reinforce the value of Galderma’s broad and comprehensive portfolio in meeting varied patient needs across Therapeutic Dermatology, Injectable Aesthetics and Dermatological Skincare Galderma (SIX: GALD), the pure-play dermatology category leader, wi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
